The lack of registration of medicines in Kenya, Tanzania and Uganda is limiting access to safe, effective, and affordable essential medicines, according to a new analysis from Newcastle University in the UK and Makerere University in Uganda, published by the Journal of the Royal Society of Medicine.

This analysis examines the lack of availability of medications within several African nations. One of the primary drivers of medicine availability is the lack of marketing authorization for existing products with these nations regulatory bodies. Instead the study finds that drugmakers have been over-applying for less medically critical medicines, slowing down the process due to a lack of regulatory agency bandwidth.

doi: https://dx.doi.org/10.1177/01410768231181263